Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026
Earth Science Tech, Inc. (OTC: ETST) reported fiscal year results for the 12 months ended March 31, 2026. According to the company, revenue rose 8% to $35.7 million, gross profit increased 5% to $25.5 million, and net income grew 11% to $3.6 million. Total assets increased 27% to $9.0 million. The company also repurchased and retired 4.0 million shares.
How this was made
The 30-second read
Why it matters
The release provides FY financial performance and quantifies share repurchases, which can affect near-term expectations for capital allocation and valuation support into the next quarterly print.
Market read
Traders can reassess ETST’s profitability trend and buyback momentum ahead of the next quarter’s results, though the article lacks detailed forward financial guidance.
What to watch
The balance sheet shows higher assets, but the excerpted financials don’t include cash flow details, leverage/financing costs, or segment profitability—key drivers for whether buybacks are value-accretive.
Background
Earth Science Tech is an OTC strategic holding company building a vertically integrated healthcare platform (telemedicine, compounding pharmacy, fulfillment).
Ticker impact
Earth Science Tech reported FY ended Mar 31, 2026 results: revenue $35.7M (+8%), net income $3.6M (+11%), and balance-sheet growth.
Moderate upside bias if the market rewards profitability improvement and buyback pace; otherwise limited impact given OTC liquidity and lack of forward guidance numbers.
The article discloses concrete FY datapoints (revenue, net income, assets) and a stated buyback activity (>7.1M shares in FY; >3.1M in Q1 FY2027), but provides no detailed segment metrics or explicit forward financial guidance beyond qualitative Q1 trajectory.
Market effects
Signals continued execution in vertically integrated telemedicine/pharmacy/fulfillment models, but no sector-wide catalyst is provided.
No specific regional macro or policy linkage is disclosed.
Primarily company-specific; no global supply-chain or regulatory developments mentioned.
Counterpoint
Revenue and earnings growth are modest in absolute terms, and OTC microcap liquidity can dominate price action despite buybacks.
Key entities
- companyEarth Science Tech, Inc.
OTC-listed strategic holding company reporting FY ended Mar 31, 2026 financial results and share repurchases.
- personGiorgio R. Saumat
CEO and Chairman who highlighted revenue/earnings growth, positive operating cash flow, and buyback activity.
